AIHW logo
METEOR logo
Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs
  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources

Bioequivalent

Identifying and definitional attributes

Metadata item type:Help on this termGlossary Item
METEOR identifier:Help on this term606099
Registration status:Help on this term
  • Commonwealth Department of Health, Standard 17/12/2015
Definition:Help on this term

In pharmacology, this term pertains to two formulations of the same drug that attain similar concentrations in blood and tissues at similar times with no clinically important differences between their therapeutic or adverse effects.

Two medicinal products containing the same active substance are considered bioequivalent if they are pharmaceutically equivalent or pharmaceutical alternatives and their bioavailabilities (rate and extent of absorption) after administration in the same molar dose lie within acceptable predefined limits.

The concept of bioequivalence is fundamental to the use of generic medicinal products.

Context:Help on this term

Pharmaceutical Benefits Scheme (PBS).

Source and reference attributes

Steward:Help on this termDepartment of Health
Reference documents:Help on this term

Harris P, Nagy S, Vardaxis N (Editors) 2010. Mosby's Dictionary of Medicine, Nursing & Health Professions, 2nd Australian and New Zealand Edition. NSW: Mosby Elsevier, page 205.

European Medicines Agency 2010. Guideline on the Investigation of Bioequivalence, 20 January 2010. Viewed 9 April 2015, http://www.ema.europa.eu/docs/en_GB/document_library/
Scientific_guideline/2010/01/WC500070039.pdf

Relational attributes

Metadata items which use this glossary item:Help on this term
Bioequivalent allowed indicator
  • Commonwealth Department of Health, Standard 17/12/2015
Bioequivalent allowed indicator code A
  • Commonwealth Department of Health, Standard 17/12/2015
Pharmaceutical Benefits Scheme (PBS) prescription—bioequivalent allowed indicator
  • Commonwealth Department of Health, Standard 17/12/2015
Pharmaceutical Benefits Scheme (PBS) prescription—bioequivalent allowed indicator, code A
  • Commonwealth Department of Health, Standard 17/12/2015
Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

<Title>

<body>
<footer>
  • View
  • Print view
  • Download
  • Word™
  • Pdf
  • Advanced Download
  • Review
  • Compare items
© Australian Institute of Health and Welfare
Version 1.0.0+20220531.2